ZHX2 and nonpapillary renal cell carcinoma: Interestingly, ZHX2 is not amplified in ccRCC (referred as KIRC in Figure 1A,B), where it is regulated mainly post-transcriptionally by pVHL loss in this cancer (Zhang et al., 2018).